The Role of Proteomics in the Diagnosis and Treatment of Women's Cancers: Current Trends in Technology and Future Opportunities
2011
The Role of Proteomics in Women's Cancers
publication
Evidence: moderate
Author Information
Author(s): Eun-Kyoung Yim Breuer, Mandi M. Murph
Primary Institution: University of Texas MD Anderson Cancer Center
Conclusion
Emerging proteomic technologies have the potential to significantly improve the diagnosis and treatment of women's cancers.
Supporting Evidence
- Breast cancer has multiple predictive tests based on tumor biomarkers.
- Cervical cancer has innovative vaccines and multiple screening options.
- Ovarian cancer lacks effective early screening tools.
Takeaway
Scientists are using new technologies to better understand and treat cancers that affect women, like breast, cervical, and ovarian cancers.
Methodology
The article reviews current trends in proteomics technologies and their applications in diagnosing and treating women's cancers.
Limitations
The study highlights the lack of early screening tools for ovarian cancer and the challenges in validating biomarkers.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website